Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Uro Gen Pharma Ltd. Transaction History
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD
- $383 Million
- Q1 2025
A detailed history of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD holds 21,823 shares of URGN stock, worth $297,665. This represents 0.06% of its overall portfolio holdings.
Number of Shares
21,823
Previous 21,823
-0.0%
Holding current value
$297,665
Previous $232,000
3.88%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$59.5 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$52.3 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$43.7 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$31.4 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$29.9 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $310M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...